These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10209810)

  • 1. Explaining community-level variance in group randomized trials.
    Feng Z; Diehr P; Yasui Y; Evans B; Beresford S; Koepsell TD
    Stat Med; 1999 Mar; 18(5):539-56. PubMed ID: 10209810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On design considerations and randomization-based inference for community intervention trials.
    Gail MH; Mark SD; Carroll RJ; Green SB; Pee D
    Stat Med; 1996 Jun; 15(11):1069-92. PubMed ID: 8804140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of cluster-randomized trials of quality improvement interventions aimed at medical care providers.
    Glynn RJ; Brookhart MA; Stedman M; Avorn J; Solomon DH
    Med Care; 2007 Oct; 45(10 Supl 2):S38-43. PubMed ID: 17909381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The advantages of community-randomized trials for evaluating lifestyle modification.
    Green SB
    Control Clin Trials; 1997 Dec; 18(6):506-13; discussion 514-6. PubMed ID: 9408714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empirical efficiency maximization: improved locally efficient covariate adjustment in randomized experiments and survival analysis.
    Rubin DB; van der Laan MJ
    Int J Biostat; 2008; 4(1):Article 5. PubMed ID: 19381345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control or overcontrol for covariates?
    Streiner DL
    Evid Based Ment Health; 2016 Feb; 19(1):4-5. PubMed ID: 26755716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When is it worth measuring a covariate in a randomized clinical trial?
    Allison DB
    J Consult Clin Psychol; 1995 Jun; 63(3):339-43. PubMed ID: 7608345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting treatment-covariate interactions using permutation methods.
    Wang R; Schoenfeld DA; Hoeppner B; Evins AE
    Stat Med; 2015 May; 34(12):2035-47. PubMed ID: 25736915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A community trial of the impact of improved sexually transmitted disease treatment on the HIV epidemic in rural Tanzania: 1. Design.
    Hayes R; Mosha F; Nicoll A; Grosskurth H; Newell J; Todd J; Killewo J; Rugemalila J; Mabey D
    AIDS; 1995 Aug; 9(8):919-26. PubMed ID: 7576328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between design and analysis for behavioral intervention trials with community as the unit of randomization.
    Green SB; Corle DK; Gail MH; Mark SD; Pee D; Freedman LS; Graubard BI; Lynn WR
    Am J Epidemiol; 1995 Sep; 142(6):587-93. PubMed ID: 7653466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large streamlined trials in cardiovascular disease.
    Calvo G; McMurray JJ; Granger CB; Alonso-García Á; Armstrong P; Flather M; Gómez-Outes A; Pocock S; Stockbridge N; Svensson A; Van de Werf F
    Eur Heart J; 2014 Mar; 35(9):544-8. PubMed ID: 24385376
    [No Abstract]   [Full Text] [Related]  

  • 12. Components of variance in a group-randomized trial analysed via a random-coefficients model: the Rapid Early Action for Coronary Treatment (REACT) trial.
    Murray DM; Feldman HA; McGovern PG
    Stat Methods Med Res; 2000 Apr; 9(2):117-33. PubMed ID: 10946430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A community trial of the impact of improved sexually transmitted disease treatment on the HIV epidemic in rural Tanzania: 2. Baseline survey results.
    Grosskurth H; Mosha F; Todd J; Senkoro K; Newell J; Klokke A; Changalucha J; West B; Mayaud P; Gavyole A
    AIDS; 1995 Aug; 9(8):927-34. PubMed ID: 7576329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of alternative study designs on the power of community randomized trials: evidence from three studies of human immunodeficiency virus prevention in East Africa.
    Todd J; Carpenter L; Li X; Nakiyingi J; Gray R; Hayes R
    Int J Epidemiol; 2003 Oct; 32(5):755-62. PubMed ID: 14559745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Community-Level Effects of Communities That Care on Adolescent Drug Use and Delinquency Using a Repeated Cross-Sectional Design.
    Rhew IC; Hawkins JD; Murray DM; Fagan AA; Oesterle S; Abbott RD; Catalano RF
    Prev Sci; 2016 Feb; 17(2):177-87. PubMed ID: 26462492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates.
    Baker SG; Fitzmaurice GM; Freedman LS; Kramer BS
    Biostatistics; 2006 Jan; 7(1):29-40. PubMed ID: 15923407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods to reduce the impact of intraclass correlation in group-randomized trials.
    Murray DM; Blistein JL
    Eval Rev; 2003 Feb; 27(1):79-103. PubMed ID: 12568061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of randomised controlled trials for producing cost-effectiveness evidence: potential impact of design choices on sample size and study duration.
    Backhouse ME
    Pharmacoeconomics; 2002; 20(15):1061-77. PubMed ID: 12456201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis strategies for a community trial to reduce adolescent ATOD use: a comparison of random coefficient and ANOVA/ANCOVA models.
    Murray DM; Lee Van Horn M; Hawkins JD; Arthur MW
    Contemp Clin Trials; 2006 Apr; 27(2):188-206. PubMed ID: 16324889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection.
    Ng BE; Butler LM; Horvath T; Rutherford GW
    Cochrane Database Syst Rev; 2011 Mar; (3):CD001220. PubMed ID: 21412869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.